Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 8 of 8 for “"Plasminogen Activator Inhibitor Type 1"”.

  1. In vivo and in vitro regulation of plasminogen activator inhibitor type-1

    … switch from producing a mixture of active tissue plasminogen activator (t-PA) and urokinase (u-PA) to producing active u-PA alone. I performed a series of experiments designed to examine the mechanism of down regulation of t-PA activity that occurred with differentiation. The results of these …

    cape-town Repository record for In vivo and in vitro regulation of plasminogen activator inhibitor type-1 (opens in a new tab)

  2. Insights Into the Dynamic Structure and Inhibitory Mechanism of Plasminogen Activator Inhibitor Type 1

    … the biochemical differences between wild-type PAI-1 (wtPAI-1) and 14-1B and to infer structural and functional details about the naturally occurring inhibitor using the structural model of the stable variant as a starting point. Using conformationally-sensitive ligands, we found that the …

    uiuc Repository record for Insights Into the Dynamic Structure and Inhibitory Mechanism of Plasminogen Activator Inhibitor Type 1 (opens in a new tab)

  3. Synthesis and structure activity relationship of novel small molecules as inhibitors of plasminogen activator inhibitor-1

    <p>Plasminogen activator inhibitor type-1 (PAI-1) is a member of the serine protease inhibitor (serpin) family. PAI-1 is involved in the regulation of fibrinolysis, which is the breakdown of blood clots. PAI-1 inhibits serine proteases tissue-type plasminogen activator (tPA) and urokinase-type

    emich Repository record for Synthesis and structure activity relationship of novel small molecules as inhibitors of plasminogen activator inhibitor-1 (opens in a new tab)

  4. Design, synthesis and evaluation of small molecules as inhibitors of plasminogen activator inhibitor-1

    <p>Plasminogen activator inhibitor type-1 (PAI-1) is a member of the serine protease inhibitor (serpin) superfamily. Excessive levels of PAI-1 inhibit urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA), which regulates fibrinolysis as well as the development of …

    emich Repository record for Design, synthesis and evaluation of small molecules as inhibitors of plasminogen activator inhibitor-1 (opens in a new tab)

  5. A Quantitative Investigation of Selected Reactions in the Fibrinolytic Cascade

    … has shown that thrombin activatable fibrinolysis inhibitor (TAFI) was unable to prolong lysis of purified clots in the presence of Lys-plasminogen (Lys-Pg), indicating a possible mechanism for fibrinolysis to circumvent prolongation mediated by activated TAFI (TAFIa). Therefore, the effects of …

    queens Repository record for A Quantitative Investigation of Selected Reactions in the Fibrinolytic Cascade (opens in a new tab)

  6. Effect of laminar shear stress on gene regulation, protein synthesis, and protein secretion by cultured human endothelial cells

    … (ie blood clot dissolving) system, tissue plasminogen activator (tPA) and plasminogen activator inhibitor, type 1 (PAI-1) were not affected by exposure to venous levels of shear stress (4 dynes/cm$\sp2$). However, at arterial shear stresses of 15 and 25 dynes/cm$\sp2$, the tPA secretion …

    rice Repository record for Effect of laminar shear stress on gene regulation, protein synthesis, and protein secretion by cultured human endothelial cells (opens in a new tab)

  7. Effect of dietary fibre on selected haemostatic variables and C-reactive protein

    … amongst others, the haemostatic factors tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor type 1 (PAI-1), factor VII (FVII) and fibrinogen and more recently, C-reactive protein (CRP), a sensitive marker of inflammation. Epidemiological studies have demonstrated an inverse …

    nwu-za Repository record for Effect of dietary fibre on selected haemostatic variables and C-reactive protein (opens in a new tab)

  8. The detection of occult metastatic disease in patients with cutaneous melanoma

    … high or low plasma levels and/or activity of plasminogen activator inhibitor type 1 (PAI1) correlate with the presence of metastatic disease in patients with melanoma. PAI1 is considered to be the main regulator of fibrinolytic activity in blood and has been identified as a key enzyme in the …

    cape-town Repository record for The detection of occult metastatic disease in patients with cutaneous melanoma (opens in a new tab)